Simone Weström

Cancer associated variant enrichment CAVE, a gene agnostic approach to identify low burden variants in chronic lymphocytic leukemia

Yaacov, Adar; Lazarian, Gregory; Pandzic, Tatjana; Weström, Simone et al.

Part of Scientific Reports, 2024

• DOI for Cancer associated variant enrichment CAVE, a gene agnostic approach to identify low burden variants in chronic lymphocytic leukemia
• Download full text (pdf) of Cancer associated variant enrichment CAVE, a gene agnostic approach to identify low burden variants in chronic lymphocytic leukemia

Patient-Specific Measurable Residual Disease Markers Predict Outcome in Patients With Myelodysplastic Syndrome and Related Diseases After Hematopoietic Stem-Cell Transplantation

Tobiasson, Magnus; Pandzic, Tatjana; Illman, Johanna; Nilsson, Lars et al.

Part of Journal of Clinical Oncology, 2024

• DOI for Patient-Specific Measurable Residual Disease Markers Predict Outcome in Patients With Myelodysplastic Syndrome and Related Diseases After Hematopoietic Stem-Cell Transplantation

BTK and PLCG2 remain unmutated in one-third of patients with CLL relapsing on ibrutinib

Bonfiglio, Silvia; Sutton, Lesley-Ann; Ljungström, Viktor; Capasso, Antonella et al.

Part of Blood Advances, p. 2794-2806, 2023

• DOI for BTK and PLCG2 remain unmutated in one-third of patients with CLL relapsing on ibrutinib
• Download full text (pdf) of BTK and PLCG2 remain unmutated in one-third of patients with CLL relapsing on ibrutinib

Mefloquine causes selective mast cell apoptosis in cutaneous mastocytosis lesions by a secretory granule-mediated pathway

Lampinen, Maria; Hagforsen, Eva; Weström, Simone; Bergström, Anna et al.

Part of Experimental dermatology, p. 1729-1740, 2022

• DOI for Mefloquine causes selective mast cell apoptosis in cutaneous mastocytosis lesions by a secretory granule-mediated pathway
• Download full text (pdf) of Mefloquine causes selective mast cell apoptosis in cutaneous mastocytosis lesions by a secretory granule-mediated pathway

Limited benefit in patients with MDS receiving venetoclax and azacitidine as a bridge to allogeneic stem cell transplantation

Jadersten, Martin; Boriskina, Ksenia; Lindholm, Carolin; Weström, Simone et al.

Part of Leukemia and Lymphoma, p. 755-758, 2022

• DOI for Limited benefit in patients with MDS receiving venetoclax and azacitidine as a bridge to allogeneic stem cell transplantation

Cancer associated variant enrichment CAVE, a gene agnostic approach to identify low burden variants in chronic lymphocytic leukemia

Yaacov, Adar; Lazarian, Gregory; Pandzic, Tatjana; Weström, Simone et al.

Part of Scientific Reports, 2024

• DOI for Cancer associated variant enrichment CAVE, a gene agnostic approach to identify low burden variants in chronic lymphocytic leukemia
• Download full text (pdf) of Cancer associated variant enrichment CAVE, a gene agnostic approach to identify low burden variants in chronic lymphocytic leukemia

Patient-Specific Measurable Residual Disease Markers Predict Outcome in Patients With Myelodysplastic Syndrome and Related Diseases After Hematopoietic Stem-Cell Transplantation

Tobiasson, Magnus; Pandzic, Tatjana; Illman, Johanna; Nilsson, Lars et al.

Part of Journal of Clinical Oncology, 2024

• DOI for Patient-Specific Measurable Residual Disease Markers Predict Outcome in Patients With Myelodysplastic Syndrome and Related Diseases After Hematopoietic Stem-Cell Transplantation

BTK and PLCG2 remain unmutated in one-third of patients with CLL relapsing on ibrutinib

Bonfiglio, Silvia; Sutton, Lesley-Ann; Ljungström, Viktor; Capasso, Antonella et al.

Part of Blood Advances, p. 2794-2806, 2023

• DOI for BTK and PLCG2 remain unmutated in one-third of patients with CLL relapsing on ibrutinib
• Download full text (pdf) of BTK and PLCG2 remain unmutated in one-third of patients with CLL relapsing on ibrutinib

Mefloquine causes selective mast cell apoptosis in cutaneous mastocytosis lesions by a secretory granule-mediated pathway

Lampinen, Maria; Hagforsen, Eva; Weström, Simone; Bergström, Anna et al.

Part of Experimental dermatology, p. 1729-1740, 2022

• DOI for Mefloquine causes selective mast cell apoptosis in cutaneous mastocytosis lesions by a secretory granule-mediated pathway
• Download full text (pdf) of Mefloquine causes selective mast cell apoptosis in cutaneous mastocytosis lesions by a secretory granule-mediated pathway

Limited benefit in patients with MDS receiving venetoclax and azacitidine as a bridge to allogeneic stem cell transplantation

Jadersten, Martin; Boriskina, Ksenia; Lindholm, Carolin; Weström, Simone et al.

Part of Leukemia and Lymphoma, p. 755-758, 2022

• DOI for Limited benefit in patients with MDS receiving venetoclax and azacitidine as a bridge to allogeneic stem cell transplantation

Exploration of novel candidate genes involved in epidermal keratinocyte differentiation and skin barrier repair in man

Zhang, Hanqing; Weström, Simone; Kappelin, Per; Virtanen, Marie et al.

Part of Differentiation, p. 19-27, 2021

• DOI for Exploration of novel candidate genes involved in epidermal keratinocyte differentiation and skin barrier repair in man

Patients with congenital ichthyosis and TGM1 mutations overexpress other ARCI genes in the skin: Part of a barrier repair response?

Zhang, Hanqian; Ericsson, Maja; Weström, Simone; Vahlquist, Anders et al.

Part of Experimental dermatology, p. 1164-1171, 2019

• DOI for Patients with congenital ichthyosis and TGM1 mutations overexpress other ARCI genes in the skin: Part of a barrier repair response?
• Download full text (pdf) of Patients with congenital ichthyosis and TGM1 mutations overexpress other ARCI genes in the skin: Part of a barrier repair response?

Quantitative image analysis of protein expression and colocalisation in skin sections

Zhang, Hanqian; Ericsson, Maja; Virtanen, Marie; Weström, Simone et al.

Part of Experimental dermatology, p. 196-199, 2018

• DOI for Quantitative image analysis of protein expression and colocalisation in skin sections

Siramesine causes preferential apoptosis of mast cells in skin biopsies from psoriatic lesions

Hagforsen, Eva; Lampinen, Maria; Paivandy, Aida; Weström, Simone et al.

Part of British Journal of Dermatology, p. 179-187, 2017

• DOI for Siramesine causes preferential apoptosis of mast cells in skin biopsies from psoriatic lesions
• Download full text (pdf) of Siramesine causes preferential apoptosis of mast cells in skin biopsies from psoriatic lesions

The endothelial adaptor molecule TSAd is required for VEGF-induced angiogenic sprouting through junctional c-Src activation

Gordon, Emma J.; Fukuhara, Daisuke; Weström, Simone; Padhan, Narendra et al.

Part of Science Signaling, 2016

• DOI for The endothelial adaptor molecule TSAd is required for VEGF-induced angiogenic sprouting through junctional c-Src activation

Quantitative analysis of immunofluorescence and in situ PLA staining using CellProfiler reveals impaired epidermal lipid processing pathway in ARCI patients with CYP4F22 mutations

Zhang, Hanqian; Virtanen, Marie; Weström, Simone; Bygum, A. et al.

Part of Journal of Investigative Dermatology, 2016

Neuropilin-1 mediates vascular permeability independently of vascular endothelial growth factor receptor-2 activation

Roth, Lise; Prahst, Claudia; Ruckdeschel, Tina; Savant, Soniya et al.

Part of Science Signaling, 2016

• DOI for Neuropilin-1 mediates vascular permeability independently of vascular endothelial growth factor receptor-2 activation

Identification and characterization of VEGF-A-responsive neutrophils expressing CD49d, VEGFR1, and CXCR4 in mice and humans

Massena, Sara; Christoffersson, Gustaf; Vågesjö, Evelina; Seignez, Cédric et al.

Part of Blood, p. 2016-2026, 2015

• DOI for Identification and characterization of VEGF-A-responsive neutrophils expressing CD49d, VEGFR1, and CXCR4 in mice and humans

Ablation of human skin mast cells in situ by lysosomotropic agents

Hagforsen, Eva; Paivandy, Aida; Lampinen, Maria; Weström, Simone et al.

Part of Experimental dermatology, p. 516-521, 2015

• DOI for Ablation of human skin mast cells in situ by lysosomotropic agents

The role of differential VE-cadherin dynamics in cell rearrangement during angiogenesis

Bentley, Katie; Franco, Claudio Areias; Philippides, Andrew; Blanco, Raquel et al.

Part of Nature Cell Biology, p. 309-321, 2014

• DOI for The role of differential VE-cadherin dynamics in cell rearrangement during angiogenesis

NRP1 Presented in trans to the Endothelium Arrests VEGFR2 Endocytosis, Preventing Angiogenic Signaling and Tumor Initiation

Koch, Sina; van Meeteren, Laurens A.; Morin, Eric; Testini, Chiara et al.

Part of Developmental Cell, p. 633-646, 2014

• DOI for NRP1 Presented in trans to the Endothelium Arrests VEGFR2 Endocytosis, Preventing Angiogenic Signaling and Tumor Initiation

The mechanisms of VEGF-A-induced recruitment of pro-angiogenic neutrophils

Massena, Sara; Christoffersson, Gustaf; Vågesjö, Evelina; Gustafsson, Karin et al.

Part of European Journal of Clinical Investigation, p. 27-27, 2013

VEGFR2 induces c-Src signaling and vascular permeability in vivo via the adaptor protein TSAd

Sun, Zuyue; Li, Xiujuan; Massena, Sara; Kutschera, Simone et al.

Part of Journal of Experimental Medicine, p. 1363-1377, 2012

• DOI for VEGFR2 induces c-Src signaling and vascular permeability in vivo via the adaptor protein TSAd